F.L. Putnam Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,259
Closed -$241K 340
2019
Q4
$241K Buy
+1,259
New +$227K 0.01% 285
2017
Q1
$1.63M Sell
6,804
-258
-4% -$60.1K 0.17% 115
2016
Q4
$1.48M Sell
7,062
-861
-11% -$178K 0.17% 103
2016
Q3
$1.82M Sell
7,923
-5,739
-42% -$1.4M 0.21% 84
2016
Q2
$3.16M Sell
13,662
-13,349
-49% -$3.08M 0.37% 69
2016
Q1
$7.24M Buy
27,011
+238
+0.9% +$68.1K 0.87% 43
2015
Q4
$8.37M Buy
26,773
+1,781
+7% +$530K 0.98% 41
2015
Q3
$6.79M Buy
24,992
+1,843
+8% +$566K 0.84% 49
2015
Q2
$7.03M Buy
23,149
+5,108
+28% +$1.52M 0.78% 52
2015
Q1
$5.37M Buy
+18,041
New +$5.14M 0.6% 60

Other funds holding AGN

F.L. Putnam Investment Management's AGN Position: Q1 2020 in Review

F.L. Putnam Investment Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,259 shares — an estimated $241K sold.

F.L. Putnam Investment Management first reported a position in AGN in Q1 2015 and held it in 10 quarters. The position peaked at $8.37M in Q4 2015. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • F.L. Putnam Investment Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • F.L. Putnam Investment Management sold 1,259 Allergan plc shares in Q1 2020, an estimated $241K.
  • F.L. Putnam Investment Management first reported a position in Allergan plc in Q1 2015 and held it in 10 quarters.
  • F.L. Putnam Investment Management's Allergan plc position peaked at $8.37M in Q4 2015.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on F.L. Putnam Investment Management's 13F filing for Q1 2020, filed 8 May 2020.